Greatline Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.75 M
- Revenue Growth 164.21%
- Profit Growth 22.00%
- Ebitda -54.29%
- Net Worth 38.02%
- Total Assets 146.17%
About Greatline Pharmaceutical
Greatline Pharmaceutical Private Limited (GPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 June 2020 (Four years and seven months 25 days old ). Its registered office is in Chitrakoot, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.75 M.
Meena Shukla and Naval Shukla serve as directors at the Company.
Company Details
-
Location
Chitrakoot, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36990UP2020PTC129778
-
Company No.
129778
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jun 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Greatline Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meena Shukla
|
Director | 20-Jun-2020 | Current |
|
Naval Shukla
|
Director | 20-Jun-2020 | Current |
Financial Performance of Greatline Pharmaceutical.
Greatline Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 164.21% increase. The company also saw a substantial improvement in profitability, with a 22% increase in profit. The company's net worth Soared by an impressive increase of 38.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greatline Pharmaceutical?
Unlock access to Greatline Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.75 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Oct 2022 | Others | ₹0.75 M | Open |
How Many Employees Work at Greatline Pharmaceutical?
Greatline Pharmaceutical has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greatline Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greatline Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.